State Price Transparency: Legislative and Regulatory Overview 2022


An increasing number of reporting regulations have been introduced and updated at the state level to address the industry trend of ever-increasing Wholesale Acquisition Cost (WAC) prices. As pharmaceutical manufacturers struggle to navigate the patchwork of regulations, a majority are finding it impossible to keep up with existing legislation and the granular details of how to report.

In this informative discussion, John Whitridge and Olivia Nweze break down the current state of drug pricing transparency laws, including price transparency disclosures themes, types of reports, and recent reporting updates for nearly a dozen states including Texas, California, and Oregon.

John Whitridge
Manager, Advisory Services

Olivia Nweze
Senior Consultant, Advisory Services

Learn more by downloading our datasheet detailing solutions to reduce compliance risk around state price transparency reporting.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article